CAND2

CAND2 Full Name

cullin-associated and neddylation-dissociated 2 (putative)

CAND2 Introduction

CAND2 (cullin-associated and neddylation-dissociated 2) has emerged as a biologically important regulator within the ubiquitin-proteasome system, a pathway that governs protein turnover and cellular homeostasis. Although CAND2 was initially considered a relatively understudied member of the cullin-associated protein family, recent molecular studies have significantly expanded our understanding of its functions. CAND2 is structurally related to CAND1 and preferentially interacts with unneddylated cullin proteins, particularly CUL1-containing SCF (SKP1-CUL1-F-box) E3 ubiquitin ligase complexes. Current evidence indicates that CAND2 acts as a specialized exchange factor that promotes the dynamic assembly and disassembly of SCF complexes, thereby influencing substrate recognition and degradation efficiency. This regulatory activity places CAND2 at the center of cellular protein quality control, making it increasingly relevant to researchers investigating ubiquitination, signal transduction, and proteostasis-associated disorders.

From a functional perspective, CAND2 is now recognized as more than a passive scaffold-associated protein. Recent studies have demonstrated that CAND2 facilitates the remodeling of SCF ubiquitin ligases and contributes to the turnover of substrates controlled by specific F-box proteins, including FBXL5-dependent pathways involved in iron metabolism and intracellular homeostasis. Multi-omics databases and expression analyses further suggest that CAND2 participates in transcriptional regulation, protein ubiquitination, and signaling pathways associated with cell growth and differentiation. Unlike the broadly expressed CAND1, CAND2 displays tissue-specific characteristics, with particularly high expression in skeletal and cardiac muscle. Translational regulation by mTORC1 signaling has been shown to increase CAND2 abundance in cardiomyocytes, indicating that CAND2 may function as a downstream effector linking nutrient-sensing pathways to adaptive and maladaptive cellular responses. These findings highlight the importance of CAND2 in maintaining the balance between protein synthesis and degradation, an area that remains a major challenge in many human diseases.

Growing evidence also connects dysregulated CAND2 activity to disease mechanisms, especially cardiovascular pathology. Experimental studies in mouse models have demonstrated that elevated Cand2 expression promotes pathological cardiac remodeling, ventricular hypertrophy, and progression toward heart failure, partly through enhancing G protein-coupled receptor kinase 5 (GRK5)-mediated hypertrophic signaling. Conversely, genetic deletion of Cand2 provides protection against adverse remodeling, suggesting that CAND2 could represent a promising therapeutic target for preventing cardiac dysfunction. Because ubiquitin ligase dysregulation is a hallmark of numerous cancers, neurodegenerative diseases, and metabolic disorders, the ability of CAND2 to modulate SCF complex diversity and substrate degradation has also attracted attention in oncology and precision medicine research. In addition, comparative studies have revealed that the plant ortholog CAND2/PMTR1 functions as a melatonin receptor required for osmotic stress tolerance, underscoring the evolutionary conservation and signaling versatility of this protein family. Collectively, current evidence positions CAND2 as an emerging regulator of ubiquitin-mediated proteostasis and a potential intervention point for cardiovascular diseases and other disorders characterized by aberrant protein degradation pathways.

Alternate Names for CAND2

CAND2; cullin-associated and neddylation-dissociated 2 (putative); cullin-associated NEDD8-dissociated protein 2; KIAA0667; TBP interacting protein; TIP120B; Tp120b; KIAA0667; CAND 2; CAND2; CAND2_HUMAN; Cullin associated and neddylation dissociated prote

• 1.Wang K, et al.; Molecular mechanisms of CAND2 in regulating SCF ubiquitin ligases. Nat Commun. 2025, 16(1):1998.
  2.Górska AA, et al.; Muscle-specific Cand2 is translationally upregulated by mTORC1 and promotes adverse cardiac remodeling. EMBO Rep. 2021, 22(12):e52170.